Find policies, billing codes, payers, states, and providers
CPT 0718T: Ultrasound-Guided Autologous Cell Injection, Supraspinatus Tendon
CPT code 0718T designates an ultrasound-guided, unilateral injection of specially prepared autologous cells into the supraspinatus tendon of the rotator cuff. This procedure represents a biologic, regenerative approach to treating tendon pathology in the shoulder and is relevant nationally as interest in autologous cell therapies grows across outpatient settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes coverage patterns and coding considerations that affect reimbursement and clinical documentation for this specific regenerative injection procedure.
Readers will learn the clinical context of the service, typical sites of service, and the primary operational considerations for billing CPT code 0718T. The report provides benchmarks where available, highlights relevant policy developments that influence payer handling, and outlines common billing and documentation issues clinics encounter when reporting an ultrasound-guided autologous cell injection into the supraspinatus tendon. Data not available in the input are noted where applicable.
Customize your policy alerts
Sign up for cpt 0718T policy alerts
Get alerted when payer policies referencing 0718T are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 0718T describes an ultrasound-guided injection of specially prepared autologous cells into the supraspinatus tendon of the rotator cuff. The biologic material is derived from tissue previously harvested from the same patient and is injected to address tendon pathology in the shoulder.
-
Service type: Biologic/autologous cell injection procedure
-
Typical site of service: Outpatient procedure setting such as an ambulatory surgery center or outpatient clinic, performed on a unilateral shoulder (one side).
Data not available in the input.